Nonsteroidal Anti-inflammatory Drugs and Endometrial Carcinoma Mortality and Recurrence
Olga B. Ioffe(University of Maryland, Baltimore), Christa Nagel(The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute), Kay J. Park(Memorial Sloan Kettering Cancer Center), Ashley S. Felix(Wake Forest University), Premal H. Thaker(Washington University in St. Louis), John F. Boggess(University of Kentucky), Richard G. Moore(University of Rochester Medical Center), Joan L. Walker(Cornell University), Saketh R. Guntupalli(University of Colorado Cancer Center), Louise A. Brinton(National Cancer Institute), David G. Mutch(Cancer Research Center), David E. Cohn(The Ohio State University), Shamshad Ali(Roswell Park Comprehensive Cancer Center), Shashikant B. Lele, D. Scott McMeekin(University of Oklahoma), Levi S. Downs(University of Toronto), Theodore M. Brasky(The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute), William T. Creasman(Medical University of South Carolina), Michael L. Pearl(Stony Brook University)
Cited by 2
Related Papers
Integrated genomic analyses of ovarian carcinoma
|Nature|2011|8.2k
The Lower Anogenital Squamous Terminology Standardization Project for HPV-Associated Lesions: Background and Consensus Recommendations from the College of American Pathologists and the American Society for Colposcopy and Cervical Pathology
|Archives of Pathology & Laboratory Medicine|2012|999
A comparison of sentinel lymph node biopsy to lymphadenectomy for endometrial cancer staging (FIRES trial): a multicentre, prospective, cohort study
|The Lancet Oncology|2017|929
<scp>FIGO</scp> staging of endometrial cancer: 2023
|International Journal of Gynecology & Obstetrics|2023|926